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Angiogenesis relies on specialized endothelial tip cells to extend toward guidance cues in order to direct
growing blood vessels. Although many of the signaling pathways that control this directional endothelial
sprouting are well known, the speciﬁc cellular mechanisms that mediate this process remain to be fully
elucidated. Here, we show that Polo-like kinase 2 (PLK2) regulates Rap1 activity to guide endothelial tip
cell lamellipodia formation and subsequent angiogenic sprouting. Using a combination of high-resolu-
tion in vivo imaging of zebraﬁsh vascular development and a human umbilical vein endothelial cell
(HUVEC) in vitro cell culture system, we observed that loss of PLK2 function resulted in a reduction in
endothelial cell sprouting and migration, whereas overexpression of PLK2 promoted angiogenesis. Fur-
thermore, we discovered that PLK2 may control angiogenic sprouting by binding to PDZ-GEF to regulate
RAP1 activity during endothelial cell lamellipodia formation and extracellular matrix attachment. Con-
sistent with these ﬁndings, constitutively active RAP1 could rescue the endothelial cell sprouting defects
observed in zebraﬁsh and HUVEC PLK2 knockdowns. Overall, these ﬁndings reveal a conserved PLK2-
RAP1 pathway that is crucial to regulate endothelial tip cell behavior in order to ensure proper vascular
development and patterning in vertebrates.
& 2015 Elsevier Inc. All rights reserved.Introduction
Angiogenesis is a highly integrative and reiterative cellular
process involving the migration and proliferation of endothelial
cells (EC) to form new blood vessels from pre-existing ones. It is
dependent on the speciﬁcation of specialized EC subtypes (Adams
and Alitalo, 2007; De Smet et al., 2009; Lamalice et al., 2007) that
play distinct roles in angiogenic sprouting. To this end, endothelial
tip cells can extend ﬁlopodia- and lamellipodia-like processes to
sense growth factors, extracellular matrix (ECM) components and
attractive/repulsive cues that direct EC sprouting and migration
(Adams and Alitalo, 2007; De Smet et al., 2009; Lamalice et al.,
2007). In contrast, endothelial stalk cells, which reside behind the
leading endothelial tip cells, proliferate to elongate the growinge, University of California, Lablood vessel. Recent studies have shown that Vascular endothelial
growth factor (VEGF) and Notch signaling tightly control the dif-
ferentiation of these EC subtypes (Gerhardt et al., 2003; Hellstrom
et al., 2007; Roca and Adams, 2007; Siekmann and Lawson, 2007;
Suchting et al., 2007). In particular, VEGF can induce tip cell spe-
ciﬁcation and the expression of the Notch ligand Delta-like 4,
which in turn activates Notch signaling in neighboring stalk cells
to suppress VEGF receptor 2 expression and tip cell behavior.
Furthermore, VEGF and other developmental signaling cues (Be-
dell et al., 2005; Herbert et al., 2009; Larrivee et al., 2009; Lee
et al., 2002; Lu et al., 2004; Park et al., 2003; Torres-Vazquez et al.,
2004; Weitzman et al., 2008) can also guide endothelial tip cell
membrane extensions to control the proper development and
patterning of the vascular network (Carmeliet and Tessier-Lavigne,
2005; Mukouyama et al., 2002; Zacchigna et al., 2008).
In order for ECs to directionally sprout and migrate to form the
vasculature, a series of organized cellular events are required for
endothelial tip cells to extend their membranes and migrate
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their distal tips to sense guidance cues in their environment and
subsequently form lamellipodia to create an EC leading edge that
protrudes toward the chemotactic signal. These EC protrusions
then attach to the ECM at focal adhesions to stabilize the sprouting
EC membrane and prepare the endothelial tip cell for subsequent
migration. A central cellular component in regulating many of
these speciﬁc cellular events is the activation of small GTPases
(Kiosses et al., 2001; Spindler et al., 2010; Wojciak-Stothard et al.,
1998). In response to VEGF, Cdc42 promotes the growth of ﬁlo-
podia and mediates cell polarization through microtubule orga-
nization (Petrovic et al., 2007), whereas Rac1, together with PAK,
controls lamellipodia generation (Kiosses et al., 1999, 2001; So-
manath and Byzova, 2009). Moreover, RhoA/ROCK and Ras-asso-
ciated protein 1 (Rap1) have also been discovered to regulate an-
giogenesis through the phosphorylation of focal adhesion kinase
(FAK) as well as the activation of β1 and αVβ3 integrins (Carmona
et al., 2009; Lakshmikanthan et al., 2011; van Nieuw Amerongen
et al., 2003; Zeng et al., 2002). Consistent with these ﬁndings, both
loss of function of Rap1 and PDZ-GEF, a guanine nucleotide ex-
change factor (GEF) for Rap1, results in vascular developmental
defects in both mouse and zebraﬁsh (Carmona et al., 2009;
Chrzanowska-Wodnicka et al., 2008; Lakshmikanthan et al., 2011;
Wei et al., 2007). Thus, speciﬁc small GTPases control distinct
cellular events during EC sprouting and discovering the factors
that regulate these small GTPases may provide insight as to how
the activity of these small GTPases are coordinated to promote
directional EC angiogenic sprouting and migration.
The polo-like kinase (PLK) family proteins have been previously
shown to play pivotal roles in regulating the cell cycle (Simmons
et al., 1992), including entry into mitosis, centrosome maturation,
and exit from mitosis with the initiation of cytokinesis (Liu and
Erikson, 2003). They contain two conserved domains – the cano-
nical serine/threonine kinase domain and the non-catalytic polo
box domain (PBD), which binds to substrates and targets the ki-
nase to speciﬁc subcellular zones (Lowery et al., 2005; Strebhardt,
2010). Upon ablation of the kinase domain, the PBD domain alone
becomes a dominant-negative form of PLKs (Seeburg et al., 2008).
Despite their roles in cell cycle regulation, recent reports have
suggested PLKs may possess additional cellular functions (Streb-
hardt, 2010). For example, Plk3 has been shown to suppress tumor
angiogenesis, and Plk3 / mice developed tumors in various or-
gans at advanced age, with enhanced angiogenesis (Xu et al., 2012,
2010a, 2010b; Yang et al., 2008). Additionally, PLK2 has been ob-
served to control dendritic spine sprouting and the density of
synapses in neurons by governing RAP1 activity via the regulation
of PDZ-GEF (Lee et al., 2011a, 2011b). Interestingly, previous stu-
dies have also revealed that human PLK2 transcripts can be ob-
served in human fetal lung, kidney, spleen and heart (Simmons
et al., 1992), and additional expression analysis showed that PLK2
may also be found more speciﬁcally expressed in the vascular
system in early developmental stages (Duncan et al., 2001; Zhong
et al., 2010), suggesting that PLK2 may also regulate vascular de-
velopment. Thus, given its role in controlling RAP1 activity, we
speculate that during vascular development, PLK2 may also serve
to mediate lamellipodia formation and attachment to the ECM in
ECs through regulating EC RAP1 function.
Here, we report that PLK2 is expressed in the vascular system
and can control angiogenesis during vascular development by
speciﬁcally regulating the EC lamellipodia but not ﬁlopodia for-
mation. Using a combination of high-resolution in vivo imaging of
zebraﬁsh vascular development and a human umbilical vein en-
dothelial cell (HUVEC) in vitro cell culture system, we observed
that loss of PLK2 function resulted in a reduction in EC sprouting
and migration, whereas overexpression of PLK2 promoted angio-
genesis. Moreover, PLK2 appears to impart its function through theregulation of RAP1 to mediate focal adhesion and lamellipodia
formation in migrating ECs. Overall, our data reveal a conserved
PLK2-RAP1 pathway that is crucial to regulate endothelial tip cell
behavior in order to ensure proper vascular development and
patterning in vertebrates.Material and methods
Zebraﬁsh strains
Embryos and adult ﬁsh were maintained under standard la-
boratory conditions as described previously (Zhang et al., 2013).
The following lines were used: Tg(kdrl:mcherry-ras)s896 (Chi et al.,
2008), Tg(kdrl:GFP)s843 (Jin et al., 2005), Tg(ﬂi1a:EGFP)y1 (Lawson
and Weinstein, 2002), and Tg(hsp70:dn-MAML-GFP)fb10 (Zhao et al.,
2014).
PLK2 sequence alignment
PLK2 sequence alignment was performed by ClustalW multi-
sequence alignment as described (Hegarty et al., 2013).
Morpholino (MO) knockdown and rescue experiments
To knockdown plk2b function, we used an ATG-MO (MO1) against
the 5′UTR adjacent to the translation start site of plk2b and a splicing
MO (MO2) against the 3′ splice site of exon 2. The MO sequences are:
MO1 (ATG-plk2b-MO): 5′-GCTGTGTGTTACTGTGCTTTCTGTC-3′ and
MO2 (splicing-plk2b-MO): 5′-TATGCAGTGTTTATCCTACCTTCTC-3′. Five
base pairs (bp) of the ATG MO was altered to create a control 5 bp
mismatched MO, which did not cause any discernible phenotypes:
(ATG-plk2b-control-MO): 5′-GCTcTcTGTTAgTGTcCTTTCTcTC-3′. One-
cell stage Tg(kdrl:mcherry-ras), Tg(ﬂi1a:eGFP) embryos were injected
with 10 ng of MO1, MO2 or control MO. To conﬁrm that MO1 blocked
the translation of plk2b, the following primers were used to PCR am-
plify a construct that fuses the plk2b 5′UTR region to GFP: plk2b-GFP-F:
5′-actgtgacagaaagcacagtaacacacagccATGGTGAGCAAGGGCGAGGA-3′
and GFP-R: 5′-TTACTTGTACAGCTCGTCCA-3′. This 5′UTR plk2b-GFP
construct was subcloned into the pCS2 vector, conﬁrmed by sequen-
cing and then transcribed into capped mRNA using a mMessage
mMachine SP6 Transcription kit (Cat. no. AM1340, Life Technologies).
50 pg of the 5′UTR plk2b-GFP RNAwith or without 10 ng of plk2bMO1
was injected into zebraﬁsh embryos at the one-cell stage. To evaluate
the MO2 function, the following primers were used to detect plk2b
exon 1-4 mRNA from 50 24 hpf (hour post-fertilization) control or
MO2 injected embryos: plk2b-sMO-rtF: 5′-GGAAATGTTACTGCCGGG-
GA-3′, plk2b-sMO-rtR: 5′-CGTTTTGCGTCTGTTGCTGA-3′. For the
dominant negative plk2b (dn-plk2b) experiments, the plk2b PBD do-
main fragment was cloned into the pCS2 vector and then in vitro
transcribed using the mMessage mMachine SP6 Transcription kit (Cat.
no. AM1340, Life Technologies). The following primers were used for
PCR of the PBD domain: plk2b-PBDF 5′-ACTCAGGGCTTCATGCCA-
GAAACGC-3′, plk2b-PBDR: 5′-GTTGCATCGCTGCAGCAGCATGTTGA-3′.
One-cell stage Tg(kdrl:mcherry-ras) or Tg(ﬂi1a:eGFP) embryos were
injected with 180 pg of dn-plk2b mRNA. For mRNA rescue experi-
ments, the plk2b coding sequence (CDS), which does not include the
plk2b ATG MO1 binding site, and the human PLK2 CDS were cloned
into the pCS2 vector and then in vitro transcribed using the mMessage
mMachine SP6 Transcription kit (Cat. no. AM1340, Life Technologies).
The following primers were used for PCR: plk2b-cdsF 5′-ATGGAGA-
CACTAAGGAATAC-3′, plk2b-cdsR: 5′-TCAGTTGCATCGCTGCAGCAG-
CATG-3′, hPLK2-cdsF 5′-ATGGAGCTTTTGCGGACTAT-3′, hPLK2-cdsR: 5′-
TCAGTTACATCTTTGTAAGA-3′. One cell stage Tg(kdrl:mcherry-ras) em-
bryos were co-injected with 10 ng of plk2bMO1 or MO2 and 80 pg of
zebraﬁsh plk2b RNA, 80 pg of human PLK2 RNA, or 100 pg, 160 pg of
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overexpression experiments, one cell stage Tg(kdrl:mcherry-ras) or Tg
(ﬂi1a:eGFP) embryos were injected with 160 pg of plk2b RNA or 80 pg
of the ca-RAP1 RNA. For all MO and RNA experiments, the average
length of each ISV and the average number of branches per ISV were
measured as described in Zebraﬁsh microscopy and imaging section.
Cell culture and immunoﬂuorescence
HUVECs were purchased from Lonza (Cat. no. CC-2157). Cells
were cultured in Endothelial Basal Medium (Cat. no. CC-3121,
Lonza) supplemented with 10% Fetal Calf Serum, bovine brain
supplement, human recombinant epidermal growth factor, peni-
cillin (50 U/ml) and streptomycin (50 mg/ml) (Cat. no. CC-4133,
Lonza). Cells grown for 24 h on coverslips were ﬁxed with 4% PFA
for 10 min at 37 °C and processed for immunohistochemistry,
which was performed using the following antibodies: anti-PLK2
(Cat. no. K2392, Sigma, 1:500), anti-pFAK (Cat. no. 611722, BD
Biosciences, 1:500), anti-Integrin αVβ3 clone LM609 (Cat. no.
MAB1976, Millipore, 1:500). Primary antibody incubations were
followed by incubation with anti-rabbit (Cat. no. A11034, Life
Technologies) or anti-mouse IgG Alexa 488 (Cat. no. A11029, Life
Technologies). Alexa 568-conjugated phalloidin was used to detect
F-actin (Cat. no. A12380, Life Technologies, 1:500) and DAPI (Cat.
no. D9564, Sigma) was used to label nuclei. To quantitate the
number of ﬁlopodia, lamellipodia, pFAK plaques, and integrin
αVβ3 plaques in cell cultures, HUVECs were ﬁxed with 4% PFA and
stained with phalloidin, anti-pFAK and anti-integrin αVβ3, re-
spectively. The number of ﬁlopodia (actin-rich ﬁnger-like protru-
sions crossing the cell edge), lamellipodia (regions of actin-rich
fringe adjacent to the leading edge), pFAK plaques, and integrin
plaques were counted for each cell (n¼10). Quantitation of the
leading edge recruitment of PLK2 protein was performed using
ImageJ software (Bivona et al., 2006). Regions of identical size
were drawn around an area at the leading edge and at the cytosol
faraway from the leading edge. The ﬂuorescence intensity was
determined for these areas of interest at each time point. Nine
regions were used to calculate each condition from nine cells.
Zebraﬁsh microscopy and imaging
Confocal, ﬂuorescence and bright-ﬁeld microscopy, as well as
live imaging of zebraﬁsh were performed using a Nikon C2 con-
focal microscope, a Leica DM IL LED and a Leica M205 FA stereo-
microscope as previously described (Hegarty et al., 2013). Zebra-
ﬁsh embryos were dechorionated, anesthetized with tricaine, and
mounted laterally in 1% agarose/egg water on a glass-bottom Petri
dish (MatTek). Because of its strong GFP brightness, Tg(ﬂi1a:EGFP)
transgenic line was used to perform time-lapse imaging as well as
to track lamellipodia and ﬁlopodia extensions (n¼10 control MO,
10 plk2b MO1, 10 dn-plk2b mRNA, and 10 plk2b mRNA). As pre-
viously described (Lamalice et al., 2007; Phng et al., 2013), ﬁlo-
podia are deﬁned as ﬁnger-like protrusions that cross the cell
membrane's edge and have widths o1 mm, and lamellipodia are
deﬁned as protrusions adjacent to the leading edge that have
stronger and broader GFP signal and widths between 1 mm and
5 mm. To evaluate the relative ISV length as well as the number of
ﬁlopodia, lamellipodia, and branching ECs in the zebraﬁsh vascu-
lature, three ISVs were measured from nine different embryos
(total measured ISVs¼27) for each condition.
Flow cytometry
Tg(kdrl:mcherry-ras) embryos were treated with SU5416 or
DMSO from 20 to 32 hpf and collected at 32 hpf. Tg(kdrl:mcherry-
ras) and Tg(kdrl:mcherry-ras; Tg(hsp70:dn-MAML-GFP) embryoswere heat-shocked from 20 to 32 hpf and collected at 32 hpf. 100
embryos for each condition were collected to generate one biolo-
gic replicate for cell sorting. Disaggregation into single-cell sus-
pension was achieved as previously described (Bertrand et al.,
2010). Endothelial cell sorting was performed on a FACS Aria 2
(Becton Dickinson, San Jose, CA) and quantitiative PCR was per-
formed using cDNA from 10,000 sorted endothelial cells per bio-
logical replicate to test plk2b expression.
Expression analysis, quantitative PCR and RT-PCR
Whole-mount in situ hybridization was performed on 16, 24, 36
and 48 hpf zebraﬁsh embryos as described previously (Hegarty
et al., 2013) using a plk2a and a plk2b RNA probe. The plk2a and
plk2b RNA probes were generated by PCR, using the following
primers: plk2aF 5′-TTCTTCGCCATGACTTTTTCTGCCA-3′, plk2aR 5′-
cttgatttaggtgacactatagaaAAGCATCCTCGATTTCCCA-3′, plk2bF 5′-
ACTCAGGGCTTCATGCCAGAAACGC-3′, plk2bR 5′-cttgatttaggtga-
cactatagaaGTTGCATCGCTGCAGCAGCATGTTGA-3′, plk2bsenseF 5′-
cttgatttaggtgacactatagaaACTCAGGGCTTCATGCCAGAAACGC-3′,
plk2bsenseR 5′-GTTGCATCGCTGCAGCAGCATGTTGA-3′. Using
Power SYBR Green PCR Master Mix (Cat. no. 4367659, Life Tech-
nologies), plk2b quantitative PCR experiments were performed
from cDNA obtained from three biologic replicate pooled samples
containing ﬂow cytometry sorted ﬁsh endothelial cells for each
represented condition. Primer sequences used are as follows:
plk2aRT-F 5′-GCAGACACCGTGGCCAGAGTACTA-3′ and plk2aRT-R
5′-GCAGGCTCATGTGAGTGCCATTGT-3′ plk2bRT-F 5′-ACAA-
CACGGTGGGCGTCCTTT-3′ and plk2bRT-R 5′-TCAGCTGGAAGG-
TAGCGGACG-3′. hPLK2 reverse transcriptase (RT)-PCR experiments
were performed from cDNA obtained from HUVECs. Primer se-
quences used for human RT-PCR are as follows: hPLK2F 5′-
GAATGCCTTGAAGACAGTACCA-3′ and hPLK2R 5′-TCAGTTA-
CATCTTTGTAAGA-3′. DNA gel band intensity was quantiﬁed using
ImageJ software.
Small molecule treatment with zebraﬁsh embryos
The VEGF pathway inhibitor SU5416 (Cat. no. S8442, Sigma)
and the Polo-like kinase inhibitor, BI 2536 (Cat. no. 45706, Sigma)
(Steegmaier et al., 2007), were dissolved in DMSO (Cat. no. 472301,
Sigma) and diluted to 400 μmol/L and 2 μmol/L with egg water,
respectively, to make the stock solution. For plk2b zebraﬁsh ex-
pression assay, 20 hpf WT embryos were placed in a solution with
1 ml of 50% DMSO or SU5416 stock solution and 19 ml of egg water
(ﬁnal concentration: 2 μmol/L SU5416 with 2.5% DMSO). Embryos
were ﬁxed 10 h post treatment and whole-mount in situ hy-
bridization was performed as described previously (Hegarty et al.,
2013). For Polo-like kinase inhibition assay, 20 hpf Tg(kdrl:GFP)
embryos were placed in a solution with 1 ml of DMSO or BI 2536
stock solution and 19 ml of egg water (ﬁnal concentration:
100 nmol/L) and imaging was performed 28 h post treatment.
Heat shock experiments with zebraﬁsh embryos
Tg(hsp70:dn-MAML-GFP) embryos were initially heat-shocked
at 20 hpf in a 42° water bath for 5 min, which was subsequently
repeated for every 4 h until 32 hpf. GFP positive and negative la-
beled embryos were then ﬁxed seperately at 32 hpf, and whole-
mount in situ hybridization was performed as described previously
(Hegarty et al., 2013).
siRNA transfections
The following human PLK2 siRNA (5′-GGACATGGCTGTGAATCAG-
3′), which was previously conﬁrmed to target human PLK2 (Lim
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non-targeting control siRNA (scrambled sequence) were purchased
from Dharmacon. HUVECs were transfected using Lipofectamine
RNAiMAX (Cat. no. 13778030, Life Technologies) according to the
manufacturer's instructions.
Lentivirus production and endothelial cell transductions
Lenti-X 293T cells (Cat. no. 632180, Clontech Laboratories) were
plated in 100 mmol/L dishes and incubated overnight. The cells
were then transfected with second generation viral packaging
vectors (Cat. no. TLP5912, Thermo scientiﬁc) as well as pWPI
empty vectors (control) (Addgene plasmid 12254) or pWPI vector
containing a ca-RAP1 expression cassette or dn-PLK2 (which only
contains PLK2 PBD domain) expression cassette before the IRES-
eGFP cassette. Virus-containing supernatant was collected after
48 h, then ﬁltered through a 0.45 μmol/L pore-size ﬁlter and
supplemented with 5 mg/ml polybrene. The ﬁltered virus-con-
taining supernatants were then added to HUVECs that were see-
ded in 6-well plates one day before transduction, and then in-
cubated overnight. Two days after transduction, the transduction
efﬁciency was checked by GFP signal. This procedure typically
resulted in infection of more than 90% of cells. Successfully
transduced GFP positive HUVECs were then used for subsequent
assays.
Two-dimensional tube formation assay
Basement membrane matrix (Cat. no. 356234, BD Biosciences)
was thawed at 4 °C overnight and diluted with an equal volume of
serum-free Endothelial Basal Medium (Cat. no. CC-3121, Lonza).
Each well of a 96-well plate was coated with 100 μl of mixed
matrix, and then incubated for 30 min at 37 °C. HUVECs trans-
fected with control siRNA, PLK2 siRNA or ca-RAP1 virus were pla-
ted on this matrix-coated well, and then allowed to adhere and
migrate for 4 h at 37 °C. Tube formation was quantiﬁed by
counting the length of formed tubes using 100 magniﬁcation
pictures that were captured and processed as described above.
Each sample was assayed in two to three random ﬁelds and in-
dependently repeated three times.
Wound healing assay
HUVECs transfected with control siRNA, PLK2 siRNA or ca-RAP1
virus were seeded on 8-well chamber slides. To create an injury to
the HUVEC monolayer, this cell monolayer was scraped with
sterile pipette tips 48 h after transfection, and then washed twice
with PBS to remove ﬂoating cells. Photographs were taken 2 h and
14 h after wound formation, and the cell-free area percentage of
each image was measured between these two time-points to cal-
culate the wound closure ratio. Each sample was assayed in two to
three random ﬁelds and independently repeated three times.
Transwell migration assay
HUVECs transfected with control siRNA, PLK2 siRNA or ca-RAP1
virus were counted and seeded on membrane inserts (8 mm pore
size) (Cat. no. 3421, Costar) in the presence of 200 μl of Endothelial
Basal Medium supplemented with 0.1% BSA. The lower chamber
contained 800 μl of Endothelial Basal Medium supplemented with
4% Fetal Calf Serum. Following a four hour incubation, cells that
had migrated into the lower compartment were ﬁxed in methanol
for 10 min and stained with Crystal Violet for 10 min. Transmi-
grated cells were counted under a Leica M205 FA stereomicro-
scope. Each sample was assayed in two to three random ﬁelds and
independently repeated three times.HUVEC adhesion assay
Glass coverslips were coated with type I collagen (Cat. no.
354236, BD Biosciences, 10 μg/ml) or ﬁbronectin (Cat. no. 354008,
BD Biosciences, 5 μg/ml), and incubated one hour at 37 °C. HUVECs
were trypsinized, and 3000 cells were seeded per coverslip. After
50 min incubation at 37 °C, the adherent HUVECs were ﬁxed with
4% paraformaldehyde, and cell numbers were counted with DAPI
staining.
HUVEC proliferation assay
To detect proliferating cells, HUVECs transfected with control
or PLK2 siRNA were counted and seeded on 4-well chamber slides
and incubated with 10 μM 5-bromo-2′-deoxyuridine (BrdU, Cat.
no. B5002, Sigma) for 6 h. HUVECs were then ﬁxed with 4% PFA
and imaged by immunoﬂuorescence microscopy using an anti-
body against BrdU (Cat. no. OBT0030, abdserotec) which was then
detected with a secondary antibody conjugated to Alexa Fluor 568.
The percentage of cells undergoing proliferation was determined
by dividing the number of BrdU positive cells by the total number
of cells labeled with DAPI nuclear stain.
HUVEC cell death assay
HUVECs transfected with control or PLK2 siRNA were counted
and seeded on 4-well chamber slides and grown for 48 h. Trans-
fected HUVECs were then ﬁxed with 4% PFA and apoptotic cells
were detected using an in situ cell death detection kit from Roche
(# 2156792). The percentage of cells undergoing apoptosis was
determined by dividing the number of TUNEL positive cells by the
total number of cells labeled with DAPI nuclear stain.
HUVEC RAP1 activity assay
RAP1 activity was measured using the RAP1 activation assay kit
(Cat. no. 17-321, Millipore), which is based on the speciﬁc binding
of a GST fusion protein containing the Rap-binding domain of
RalGDS (RBD-GST) to the active GTP-bound form of RAP1. Brieﬂy,
the GTP-bound RAP1 was pulled down using RBD-GST, which was
immobilized to glutathione agarose beads. Precipitated GTP-bound
RAP1 and total RAP1 as input control were identiﬁed by SDS-PAGE
(12%) gels and western blot using a polyclonal anti-RAP1 antibody.
RAP1-GTP and total RAP1 band intensities were quantiﬁed using
ImageJ software.
Western blot analysis
Western blots were performed according to the manufacturer's
instructions using the following primary antibodies: anti-PLK2
(Cat. no. K2392, Sigma, 1:1000), anti-GAPDH (Cat. no. GT239,
GeneTex, 1:500) and anti-PDZ-GEF1 (Cat. no. WH0009693M1,
Sigma, 1:1000). Gel band intensity was quantiﬁed using ImageJ
software.
PLK2 and PDZ-GEF1 co-immunoprecipitation assay
HUVECs were rapidly lysed at 4 °C, and the whole-cell lysates
were precleared with protein A-agarose beads (Cat. no.
11719408001, Roche) for three hours at 4 °C. The supernatants
were incubated overnight at 4 °C with 1 μg of rabbit anti-PLK2
antibody (Cat. no. K2392, Sigma) or rabbit immunoglobulin G (IgG)
as a negative control. On the next day, 50 μL of protein A-agarose
beads was added to the immunoprecipitation tube and incubated
at 4 °C for three hours. After washing, the bead/protein complexes
were boiled in sample loading buffer and then identiﬁed by SDS-
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WH0009693M1, Sigma).
Statistical analyses
Quantitative statistical data are shown as the mean7standard
error of the mean (SEM) for 3 to 4 separate experiments. P-values
of group comparisons were obtained by using unpaired two tailed
Student's t-test analysis. Multi-group statistical signiﬁcance was
evaluated by one-way analysis of variance (ANOVA) with Turkey's
multiple comparison test. Statistical signiﬁcance was concluded
when P-values were o0.05.Results
Endothelial cell expression of PLK2 is conserved in vertebrates
Because PLK2 has been recently reported to regulate RAP1 ac-
tivity in neurons (Lee et al., 2011a, 2011b) and RAP1 is required for
angiogenesis (Carmona et al., 2009; Lakshmikanthan et al., 2011),
we postulated that PLK2 may also mediate endothelial cell
sprouting. Thus, we initially examined the expression of PLK2 in
both HUVECs and the developing zebraﬁsh vasculature (Fig. 1;
Figs. S1 and S2). Reverse transcription (RT)-PCR and western blot
analysis revealed that PLK2 transcript and protein, respectively,
were expressed in HUVECs (Fig. S1A–C). Furthermore,Fig. 1. PLK2 is expressed in endothelial cells. (A–B′′) Immunostaining of HUVECs revea
shows that PLK2 can aggregate at the leading edge of extending ECs (arrowhead). (A an
actin staining (red). DAPI nuclear staining (blue). Scale bar, 40 μm. (C) Quantitative mea
(Mean7s.e.m. *p¼0.0056 by Student's t-test). (D–F) in situ hybridization shows that plk
and 48 hpf (n¼28/30). (D′–F′) Enlarged image of the boxed area of D–F shows that plk2
body and tail.immunohistochemistry showed that PLK2 can also aggregate in
regions of the lamellipodia of migrating HUVECs as detected by
the colocalization of PLK2 with the thick cortical network of actin
ﬁlaments in the extending EC membrane (Fig. 1A–C, arrowheads).
Protein sequence comparison using the ClustalW program re-
vealed that PLK2 is highly conserved across vertebrate species (Fig.
S3A) and genetic analysis showed that the plk2 zebraﬁsh ortholog
may be gene duplicated, resulting in a plk2a and a plk2b gene on
chromosome 10 and 8, respectively (Fig. S3B and C). Additionally,
zebraﬁsh Plk2a and Plk2b proteins share 74% and 70% homology
with human PLK2, and plk2b appeared to be more closely syntenic
than plk2a to mammalian PLK2 (Fig. S3B). Whole mount in situ
analysis showed that plk2b was expressed predominantly in the
developing vasculature further supporting the conserved EC role
of PLK2 (Fig. 1D–F, Fig. S2), whereas plk2a appeared to be mainly
expressed in the nervous system consistent with PLK2’s function
in neurons (Fig. S4A–D, yellow arrowheads). As a result, we fo-
cused on the role of zebraﬁsh Plk2b to further understand the role
of PLK2 in vascular development.
Because VEGF and Notch signaling can promote and inhibit
angiogenesis, respectively, we investigated whether these signal-
ing pathways may alter PLK2 expression. As a result, we observed
that both PLK2 transcript and protein levels were increased in
VEGF-treated HUVECs (Fig. S1A–C), whereas zebraﬁsh embryos
treated with the VEGF inhibitor SU5416 at 20 hpf exhibited sig-
niﬁcantly reduced plk2b EC expression by 32 hpf (Fig. S1E and H).
In contrast, Notch inhibition in Tg(hsp70:dn-MAML-GFP) zebraﬁshls that PLK2 is expressed in ECs. (B–B′′) Enlarged image of the boxed area in A–A′′
d B)-merge; (A′ and B′)-anti-PLK2 immunostaining (green); (A′′ and B′′)-phalloidin
surements of PLK2 localized at the leading edge and in the cytoplasm of HUVECs
2b is expressed in the zebraﬁsh vasculature at 16 hpf (n¼31/31), 24 hpf (n¼46/47),
b is expressed in the cardinal vein, aorta, and intersomitic vessels of the zebraﬁsh
H. Yang et al. / Developmental Biology 404 (2015) 49–6054embryos at 20 hpf resulted in increased plk2b expression by 32 hpf
(Fig. S1G and I). Finally, we observed that expression of plk2b, but
not plk2a, was overall signiﬁcantly downregulated by in situ and
quantitative PCR in cloche mutants which lack ECs (Stainier et al.,
1995) (Fig. S5).
PLK2 is required for endothelial cell sprouting and migration
Because of its EC expression and localization at the leading
edge of sprouting ECs, we next performed PLK2 knockdown and
overexpression experiments in vivo and in vitro in zebraﬁsh and
HUVECs, respectively, to investigate whether PLK2 could regulate
EC sprouting and migration. To this end, we generated a plk2b ATG
MO (MO1) and a plk2b splice MO (MO2), which target the trans-
lation initiation site and its surrounding sequences and the splice
junction boundary sequences between exon 2 and intron 2, re-
spectively (Fig. S6A–H). 10 ng of either MO1 or MO2 injected into
zebraﬁsh Tg(kdrl:mcherry-ras) embryos, in which endothelial cells
are labeled in red, resulted in a signiﬁcant reduction in inter-
somitic vessel (ISV) length (Fig. 2B, C and I; Fig. S6I). In particular,
some ISVs failed to migrate dorsally beyond the horizontal myo-
septum to form the dorsal longitudinal anastomotic vessel (DLAV)Fig. 2. plk2b regulates endothelial cell sprouting. (A–D) Fluorescence micrographs sho
underdeveloped intersomitic vessel sprouting (open arrowheads) at 36 hpf. (A) control
(n¼89/137); (D) dn-plk2b RNA – dominant negative plk2b (n¼49/85). Injecting (E) 80 p
vascular sprouting defect. (G) Injecting 80 pg of plk2b RNA into wild-type Tg(kdrl:mch
However, (H) injecting 160 pg of plk2b resulted in increased ISV spouting and branch
asterisk); bottom, dorsal aorta/cardinal vein. Scale bar, 80 μm. Quantitative measurem
corresponding condition. Mean7s.e.m. *po0.05 by ANOVA.(Fig. 2B, C and open arrowheads). Furthermore, injecting dominant
negative plk2b RNA (dn-plk2b), which lacks the Plk kinase domain,
into Tg(kdrl:mcherry-ras) zebraﬁsh embryos or treating Tg(kdrl:
GFP) zebraﬁsh embryos with the polo-like kinase inhibitor, BI
2536, could also reduce ISV length (Fig. 2D and I; Fig. S6I and K).
Finally, we observed that these loss of plk2b function embryos
appeared to otherwise develop and swim normally compared to
age-matched MO controls (Fig. S7), supporting that the phenotypic
defects of the loss of plk2b function embryos were vascular-
speciﬁc.
To validate the effect of the plk2b MOs, we attempted to rescue
the plk2bmorphant knockdowns by co-injecting zebraﬁsh plk2b or
human PLK2 RNA. Co-injecting 80 pg of wild-type zebraﬁsh plk2b
mRNA or human PLK2mRNAwith plk2bMOs signiﬁcantly reduced
the ability of plk2b MOs to cause the EC sprouting defect (Fig. 2E, F
and I; Fig. S6I), in effect rescuing the plk2b MO knockdowns. Al-
though injecting 80 pg of wild-type plk2b into zebraﬁsh wild-type
embryos had no effect on zebraﬁsh development (Fig. 2G), in-
jecting 160 pg of wild-type plk2b interestingly led to increased
endothelial ISV branching and connections between neighboring
ISVs at the horizontal myoseptum (Fig. 2H, J and arrowheads;
Fig. S6I).w that loss of plk2b function in Tg(kdrl:mcherry-ras) zebraﬁsh embryos results in
MO (n¼0/149); (B) plk2b ATG MO (MO1) (n¼125/171); (C) plk2b splice MO (MO2)
g of plk2b (n¼31/103) or (F) 80 pg of hPLK2 (n¼24/71) can rescue the plk2b MO1
erry-ras) embryos did not cause any signiﬁcant vascular phenotypes (n¼0/105).
es (arrowheads) (n¼91/145). Top, dorsal longitudinal anastomotic vessel (yellow
ents of (I) intersomitic vessel length and (J) the number of ISV branches for each
H. Yang et al. / Developmental Biology 404 (2015) 49–60 55To further analyze the direct effects of PLK2 deﬁciency on EC
migration, we disrupted PLK2 function in HUVECs using a PLK2
siRNA that has been shown to successfully inhibit PLK2 protein
expression in human cells (Lim et al., 2015; Mbefo et al., 2010;
Warnke et al., 2004). When compared to control siRNA, PLK2
siRNA knockdown inhibited the ability of VEGF and bFGF stimu-
lated HUVECs to form a network of interconnecting branches as
well as to migrate as detected in in vitro tube formation assays and
transwell migration assays, respectively (Fig. 3A–D, G and H).
Additionally, using wound healing assays where conﬂuent mono-
layer cultures of HUVECs were wounded with a pipette tip, we
observed that PLK2 siRNA HUVECs exhibited signiﬁcantly delayed
migration and wound healing closure when compared to controls
(Fig. 3E–F′ and I). To conﬁrm that the delay in wound healing was
due to a cell migration defect rather than a cell proliferation or cell
death defect, we performed BrdU labeling and TUNEL staining
experiments and observed no signiﬁcant difference in cell pro-
liferation or cell apoptosis between PLK2 and control siRNA
knockdowns (Fig. 3J and K). Finally, we transfected HUVECs with
human dominant negative PLK2 RNA (dn-PLK2) to conﬁrm the
PLK2 siRNA ﬁndings and discovered that dn-PLK2 RNA can also
block the endothelial cell migration in in vitro tube formation,Fig. 3. PLK2 regulates endothelial cell migration. (A and B) EC tube formation assays, (C a
when compared to control siRNA knockdown, PLK2 siRNA knockdown in HUVECs results
EC migration formation (p¼0.0185), and (F, F′ and I) slower EC wound healing/closure,
(J) BrdU positive cells and (K) TUNEL staining positive cells in control and PLK2 siRNA
liferation (p¼0.6007) and apoptosis (p¼0.7970). (A, B, E–F′) Scale bar, 1.6 mm. (C and D)
by Student's t-test.transwell migration and wound healing assays (Fig. S8). Together,
these studies show that PLK2 functions to regulate the migration
of endothelial cells in vivo and in vitro.
PLK2 regulates lamellipodia but not ﬁlopodia formation through
mediating EC cell adhesion
Angiogenesis is dependent on the initiation and stabilization of
EC cell membrane extensions to form sprouting EC branches. In
order to further investigate how PLK2 may regulate angiogenesis,
we examined both ﬁlopodia and lamellipodia formation in vivo
using time-lapse imaging of the zebraﬁsh vasculature as well as in
vitro using HUVECs. We observed that loss of plk2b function in
zebraﬁsh Tg(ﬂi1a:eGFP) embryos and loss of PLK2 function in HU-
VECs resulted in signiﬁcantly reduced lamellipodia numbers when
compared to controls (Fig. 4A, B, G and H; Fig. S9A–C; Movie S1–S3).
Conversely, in zebraﬁsh overexpressing plk2b, we observed in-
creased lamellipodia numbers and endothelial branches (Fig. 2H and
J; Fig. 4G; Fig. S6I; Fig. S9D, Movie S4). However, we did not observe
a signiﬁcant difference in ﬁlopodia numbers after perturbing PLK2
function in HUVECs and zebraﬁsh embryos (Fig. 4G, H).nd D) transwell EC migration assays, and (E–F′) wound healing EC assays show that
in (B and G) decreased EC network/tube formation (p¼0.0028), (D and H) reduced
respectively (p¼0.0114). (J and K) Quantitative measurements of the percentage of
transfected HUVECs show that PLK2 knockdown does not affect HUVEC cell pro-
Scale bar, 400 μm. hpw – hours post wounding. Mean7s.e.m. *po0.05, **po0.01
Fig. 4. PLK2 regulates endothelial cell lamellipodia and cell adhesion formation. (A–A′) 26 hpf plk2b MO1 injected Tg(ﬂi1a:eGFP) ﬁsh (n¼31/40) exhibit fewer lamellipodia,
and extending intersomitic vessels compared to age-matched control MO injected Tg(ﬂi1a:eGFP) ﬁsh (n¼0/48). Scale bar, 40 μm. Top, dorsal longitudinal anastomotic vessel;
bottom, dorsal aorta/cardinal vein. (B–B′) Phalloidin staining reveals that PLK2 siRNA transfected HUVECs display reduced lamellipodia when compared to control siRNA
transfected HUVECs. Scale bar, 20 μm. Immunostaining of (C–C′′′, D–D′′′) pFAK and (E–E′′′, F–F′′′) integrin αVβ3 shows that focal adhesions and integrins, respectively, are
localized to the lamellipodia of migrating/extending (C and E) control siRNA transfected HUVECs, but they fail to organize and aggregate in (D and F) PLK2 siRNA transfected
HUVECs. Scale bar, 10 μm. (G) Quantitative measurements of the number of lamellipodia and ﬁlopodia reveal that zebraﬁsh plk2b knockdowns have reduced lamellipodia but
relatively the same number of ﬁlopodia (ﬁnger-like protrusions crossing the cell edge) when compared to controls. Conversely, zebraﬁsh RNA injection of 160 pg plk2b
resulted in more lamellipodia only. (H) Quantitative measurements of the number of lamellipodia and ﬁlopodia reveal that human PLK2 knockdowns have reduced la-
mellipodia (p¼0.0023) but relatively the same number of ﬁlopodia (p¼0.2615) when compared to controls. (I) Quantitative measurements of the number of pFAK
(p¼0.0143) and integrin αVβ3 plaques (p¼0.0224) reveals that knockdown of PLK2 reduced the number of cell adhesions in HUVECs. (J) EC adhesion assays show that PLK2
siRNA HUVECs adhered less to type I collagen (p¼0.0017) and ﬁbronectin-coated coverslips (p¼0.0061) compared to control siRNA HUVECs. Arrowheads and arrows point
to lamellipodia and ﬁlopodia, respectively. Red – phalloidin/actin staining; Blue – DAPI staining; Green – (A) GFP, (C–D) pFAK, or (E and F) integrin αVβ3. Mean7s.e.m.
*po0.05, **po0.01 by ANOVA for G and Student's t-test for H–J.
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maintain EC lamellipodia protrusions during angiogenesis, we next
examined the localization of phosphorylated focal adhesion kinase
(pFAK) and integrin αVβ3 in control and PLK2 siRNA transfected
HUVECs. PLK2 siRNA transfected HUVECs failed to form stable cell
adhesion plaques as detected by pFAK and integrin αVβ3 im-
munostaining and to organize actin ﬁlaments to develop a leading
edge for lamellipodia protrusions (Fig. 4C–F and I). As a result, we
observed reduced numbers of PLK2 siRNA transfected HUVECs ad-
hering to either collagen or ﬁbronectin coated coverslips (Fig. 4J).
Overall, these studies reveal that PLK2 may mediate angiogenesis
through regulating EC adhesion and lamellipodia stabilization.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.05.011.
RAP1 acts downstream of PLK2 to regulate endothelial cell sprouting
and migration
Previous studies have shown that PLK2 can mediate sprouting
in neuronal cells through regulating the ability of PDZ-GEF1 toexchange GDP for GTP on RAP1 and thereby activating RAP1 (Lee
et al., 2011b). Because RAP1 has also been recently reported to
mediate angiogenesis through the phosphorylation of FAK and the
subsequent activation of integrins (Carmona et al., 2009), we in-
vestigated whether PLK2 may regulate RAP1 during EC focal ad-
hesion formation and EC migration. Using a RAP1-GTP binding
assay (de Rooij and Bos, 1997), which monitors RAP1 activity
through the analysis of RAP1-GTP binding to a GST fusion protein
containing the RAP-binding domain (RBD) of RalGDS (RBD-GST),
we examined the levels of activated RAP1-GTP in PLK2 and control
siRNA transfected HUVECs. As a result, we observed reduced ac-
tivated RAP1-GTP in PLK2 siRNA transfected HUVECs when com-
pared to controls, suggesting that PLK2 may be required to activate
RAP1 (RAP1-GTP) in ECs to bind to its effector (Fig. 5A and B).
Finally, to investigate whether PLK2 in ECs may regulate RAP1
activity through PDZ-GEF1 as observed in neurons, we performed
PLK2 immunoprecipitations in HUVECs and observed that PDZ-
GEF1 could interact in a protein complex with PLK2 (Fig. 5C).
Because these data suggest that PLK2 may interact with PDZ-
GEF to activate Rap1 to mediate focal adhesion assembly, we
Fig. 5. PLK2 regulates HUVEC migration in vitro via RAP1 activity. (A) RAP1 immunoblot of RAP1-GTP binding assays shows that there is less RAP1-GTP in PLK2 siRNA HUVECs
than in control siRNA HUVECs (22 kDa). PLK2 immunoblot shows the efﬁciency of PLK2 siRNA knockdown in HUVECs. (B) Quantitative measurements show that the ratio of
RAP1-GTP/Total RAP1 is less in PLK2 siRNA (Mean7s.e.m. *p¼0.015 by Student's t-test). (C) Immunoprecipitation (IP) of HUVEC lysates with anti-PLK2 antibody reveals that
PLK2 interacts in a complex with PDZ-GEF1 (180 kDa). Western analyses of immunoprecipitations were performed with anti-PDZ-GEF (WB: PDZ-GEF) and anti-PLK2
antibodies (WB: PLK2). IP IgG – control antibody; α-PLK2 – anti-PLK2 antibody. (D) EC tube formation assays, (E) Transwell EC migration assays, and (F and G) wound healing
EC assays show that ca-RAP1 virus can rescue the PLK2 siRNA knockdown HUVEC (compare D′′ to D′′′) EC network/tube formation, (compare E′′ to E′′′) cell migration, and
(compare F′′, G′′ to F′′′, G′′′) wound healing defects. (D–D′′′, F–F′′′, G–G′′′) Scale bar, 1.6 mm. (E–E′′′) Scale bar, 400 μm. (H–J) Quantitative measurements were performed on
(H) EC tube formation assays, (I) transwell EC migration assays, and (J) wound healing EC assays. hpw-hours post wounding. Mean7s.e.m. *po0.05, **po0.01 by ANOVA for
H–J.
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H. Yang et al. / Developmental Biology 404 (2015) 49–6058investigated whether a constitutively active RAP1 (ca-RAP1)
(Brinkmann et al., 2002) protein might be able to rescue the PLK2
knockdown angiogenesis phenotype. To this end, we infected the
ca-RAP1 virus into PLK2 siRNA HUVECs and discovered that the ca-
RAP1 virus could partially rescue the EC migration and sprouting
defects observed in PLK2 knockdown HUVECs (compare Fig. 5D′′–
G′′ to D′′′–G′′′, H–J). Additionally, we attempted to rescue the
zebraﬁsh plk2b MO knockdowns with ca-RAP1 RNA. Co-injecting
100 pg of ca-RAP1 RNA with plk2b MO1 signiﬁcantly reduced the
ability of plk2b MO1 to cause the EC sprouting defect (Fig. S10A;
Fig. S6I), in effect rescuing the plk2b MO1 knockdowns. Moreover,
co-injecting higher amounts of ca-RAP1 RNA (160 pg) led to not
only rescue of the plk2b MO1 EC defect, but also some ectopic EC
sprouting into the somites (Fig. S10B, yellow arrowheads and D;
Fig. S6I). Consistent with these ﬁndings, injecting 80 pg of ca-RAP1
RNA into wild-type embryos also resulted in ectopic EC sprouting
as well (Fig. S10C, yellow arrowheads and D; Fig. S6I). To in-
vestigate how ca-RAP1 might rescue the PLK2 knockdown HUVEC
migration defects, we examined the ability of ca-RAP1 infected
PLK2 siRNA HUVECs to develop focal adhesions. We discovered
that the ca-RAP1 virus could rescue the reduced numbers of focal
adhesions as well as the type I collagen and ﬁbronectin cell ad-
hesion defects in PLK2 siRNA HUVECs when compared to control
virus infected PLK2 siRNA HUVECs (compare Fig. 6C, G to D, H; Fig.
S11A–D). Although ca-RAP1 could rescue the PLK2 knockdown
angiogenesis phenotype through restoring lost focal adhesions in
HUVECs, interestingly, we did not observe a signiﬁcant increase in
EC sprouting, migration and focal adhesion formation between
control and ca-RAP1 infected HUVECs (compare Fig. 5D–G to D′–G′
and H–J; Fig. 6A, E to B, F; Fig. S11A and B), suggesting that RAP1
may be required but not sufﬁcient for EC sprouting in vitro. Overall,
these studies reveal that PLK2 may mediate angiogenesis through
regulating RAP1 activity and localization.Discussion
Angiogenesis is dependent on endothelial tip cells to lead new
blood vessels during vascular development. In response to gui-
dance cues, these endothelial tip cells directionally extend their
membranes through a series of organized cellular processes in-
cluding the development of ﬁlopodia and lamellipodia. Here, we
show that PLK2 speciﬁcally regulates EC lamellipodia but not ﬁ-
lopodia formation to direct EC sprouting and angiogenesis. Con-
sistent with its recently reported role in neurons (Lee et al., 2011a,Fig. 6. PLK2 regulates focal adhesion formation and integrin localization through RAP1 a
reduced EC sprouting and lamellipodia defects observed in PLK2 siRNA HUVECs through
(compare G to H). Arrowheads point to lamellipodia extension as detected by the organ
Green – (A′–D′) anti-pFAK; or (E′–H′) anti-integrin αVβ3; Red – phalloidin; Blue – DAPI2011b), we observed that PLK2 can control RAP1 activity in ECs.
Although it remains unclear as to precisely how PLK2 may regulate
neuronal sprouting, we discovered that in ECs, PLK2 interacts with
PDZ-GEF to activate RAP1 in order to regulate the formation of EC
focal adhesions and the subsequent growth of lamellipodia. Si-
milar to the loss of RAP1 function EC defects (Carmona et al., 2009;
Lakshmikanthan et al., 2011), loss of PLK2 function results in re-
duced EC attachment, lamellipodia structures, and overall
angiogenesis.
Previous studies have reported that PLK2 is expressed in Xe-
nopus and mouse embryonic brains and blood vessels (Duncan
et al., 2001; Visel et al., 2004). Furthermore, it has been shown to
be more than 2.5-fold greater in mouse tip ECs than in stalk ECs
(del Toro et al., 2010). In line with these ﬁndings, we discovered
that PLK2 is also expressed in both HUVECs and the zebraﬁsh
vasculature and is further regulated by the VEGF and Notch sig-
naling pathways, which are known to control angiogenesis. Thus,
these ﬁndings suggest that PLK2’s function may be conserved
across vertebrates to regulate blood vessel formation.
In support of its role in angiogenesis, PLK2 knockdowns re-
sulted in EC sprouting and migration defects in both HUVECs and
zebraﬁsh. Because PLK2 was previously shown to regulate RAP1
through interactions with PDZ-GEF in neurons (Lee et al., 2011b)
and RAP1 is crucial for EC sprouting (Carmona et al., 2009;
Chrzanowska-Wodnicka et al., 2008; Lakshmikanthan et al., 2011;
Wei et al., 2007), we attempted to rescue the PLK2 knockdown EC
defect using a constitutively activated RAP1 (ca-RAP1) protein. We
discovered that ca-RAP1 could partially rescue this phenotype
suggesting that PLK2 may regulate more than RAP1 activity during
EC sprouting and migration. Given that other small GTPases, in-
cluding RhoA, Rac1, and Cdc42, have been reported to regulate
endothelial tip cell ﬁlopodia, lamellipodia, cell adhesion, and stress
ﬁber formation (Kiosses et al., 2001; Spindler et al., 2010; Wojciak-
Stothard et al., 1998), it is possible that PLK2 may regulate these
other small GTPases through interactions with their respective
GEFs. In particular, we postulate that a likely additional candidate
that PLK2 may regulate would be Rac1 because of its role in la-
mellipodia formation. Finally, it is noteworthy that ca-RAP1 in
control ECs did not result in a signiﬁcant increase in EC sprouting,
suggesting that RAP1 is required but not sufﬁcient for EC sprout-
ing. Thus, it will be particularly interesting in the future to ex-
amine whether PLK2 may regulate other small GTPases during
angiogenesis.
Actin-rich ﬁlopodia and lamellipodia protrusions have been
proposed to drive EC sprouting and vascular patterning. Filopodiactivity. (A–H) Immunoﬂuorescence studies show that ca-RAP1 virus can rescue the
restoring focal adhesion formation (compare C to D) and integrin αVβ3 organization
ization of F-actin (phalloidin) at the leading edge of extending HUVEC membranes.
. Scale bar, 20 μm.
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tight parallel bundles of ﬁlamentous actin (F-actin). On the other
hand, lamellipodia are short veil-like structures that are in close
proximity to the plasma membrane and exhibit a highly branched
actin network (Huber et al., 2003; Mattila and Lappalainen, 2008;
Pollard and Borisy, 2003). In many cell types, both cellular pro-
cesses are able to explore the environment for attractive and re-
pulsive guidance cues (Huber et al., 2003), and form focal adhe-
sions between the cytoskeleton and the ECM to control directional
migration (Deﬁlippi et al., 1999). Interestingly, in our knockdown
studies, we discovered that PLK2-deﬁcient ECs, which exhibit ar-
rested EC sprouting and migration, were able to form ﬁlopodia but
not lamellipodia, thus suggesting that ﬁlopodia may not be sufﬁ-
cient to promote EC sprouting. These results are consistent with
those recently reported where ECs treated with low levels of La-
trunculin B, which inhibits F-actin polymerization and ﬁlopodia
formation, were still able to form lamellipodia and sprout, albeit
inefﬁciently (Phng et al., 2013). However, these EC ﬁndings are in
contrast to studies that report that ﬁlopodia may be sufﬁcient to
guide neuronal and retinal growth cones (Bentley and Toroian-
Raymond, 1986; Chien et al., 1993; Zheng et al., 1996). Although
ﬁlopodia may not be enough to promote EC sprouting and mi-
gration, they may be still required for proper vascular develop-
ment including efﬁcient EC migration and anastomosis as pre-
viously suggested (Phng et al., 2013). Lastly, our data also suggests
that lamellipodia may not be required to form ﬁlopodia as we did
not observe any demonstrable ﬁlopodia defects in the PLK2
knockdown ECs, which exhibited signiﬁcantly decreased lamelli-
podia. Thus, future detailed EC cellular studies will be necessary to
further examine the speciﬁc roles of ﬁlopodia and lamellipodia in
EC sprouting and migration.
Finally, although Polo-like kinase proteins have been shown to
regulate the cell cycle, they may also participate in regulating
angiogenesis and vascular development. Here, we showed that
PLK2 is expressed in the vascular system and functions to control
vascular development through regulating small GTPases involved
in lamellipodia formation of ECs during angiogenesis. Further-
more, PLK3 has been shown to suppress tumor angiogenesis
through phosphorylating HIF-1α and PTEN, which destabilizes
HIF-1α and stabilizes PTEN, a known regulator of HIF-1α and tu-
mor angiogenesis (Xu et al., 2012, 2010a, 2010b; Yang et al., 2008).
Given the biological relationship between angiogenesis, tissue
development, and tumor growth, these ﬁndings raise the possi-
bility that other PLK family members may also regulate angio-
genesis and support further studies to explore their role in vas-
cular development.Acknowledgments
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